Categories
Connect with us on LinkedIn
Lessons learned from powering the WHO Solidarity trial
Watch this webinar to learn how Castor's solutions have helped the WHO in running their Solidarity Therapeutics Trial
Executive interview with Derk Arts at Fierce JPM Week 2022
Watch this webinar for pandemic lessons the healthcare industry learned that can help tackle longtime challenges in clinical...
Castor Delivers Strong Finish to 2021, Continues Expansion into US Market
Castor announced transformative growth with anticipated topline acceleration driven by the company’s momentous US market expansion
Case Study: COVID-RED Uses Castor’s Decentralized eClinical Platform
Download this case study to learn how Castor responded to the disruptive impact of COVID-19 and helped the...
Castor Provides Continued Support to the World Health Organization, Powering the World’s Largest Adaptive COVID-19 Trial
Castor announced continued support for the WHO Solidarity trial, the world's largest adaptive COVID-19 trial.
Introducing Castor Connect
Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with...
Research Continuity During COVID-19
Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with...
Common shortcomings of clinical research data for PMCF
The following is an excerpt from our free whitepaper ‘Satisfying PMCF requirements by utilizing IIS data’. Click here...
eConsent – The Enrollment Solution for Decentralized Trials
Join this webinar to understand how eConsent works, where it falls in the regulatory guidelines & see a...
Castor Announces Partnership With Click Therapeutics to Support Decentralized Clinical Trials
Hoboken, New Jersey: September 2, 2020: Castor, a leading provider of clinical trial technology that automates the research...
Castor Raises a $12M Series A to Further Their Support for COVID-19 Research
With 4,000 live studies and 2M enrolled patients across 90 countries, Castor will use the funding to further...
An Expert Panel on Decentralized and Hybrid Trials, Pre and Post COVID-19
The world may have changed seemingly overnight, but clinical research and medical innovation must continue now more than...
What Will Trial Enrollment & Engagement Look Like in a Socially-Distanced World?
When the COVID-19 pandemic began, the industry needed to focus immediately on research continuity and determine how to...
Using Decentralized Trial Technology to Ensure Study Continuity and Data Quality During COVID-19 and Beyond
Download this white paper to learn why patient-centric, remote research technologies such as eConsent, EDC, and ePRO are...
Protocol Deviations in Clinical Trials: Understanding the FDA’s Guidance
Protocol deviations can seriously impact the integrity of clinical trials, and with regulatory scrutiny growing, it’s crucial to...
Castor vs. the Coronavirus and COVID-19
Last updated on June 30, 2020 For existing and new Castor customers Castor will continue to deliver its...
An Engineering Spotlight: What’s it like to ‘crunch the code’ at Castor?
Bas is one of our Senior Software Engineers. Having recently joined our team of Castorians, I wondered how...
Impact of ISO 14155 on PMCF Investigations Under the MDR
Through the Medical Device Regulation (MDR) and new version of ISO 14155, the regulatory landscape for clinical investigations with...
Connect with us on LinkedIn
